The present invention concerns nucleic acid sequences and amino acid sequences of dominant negative variants of kinases, i.e. of sequences which inhibit activity of kinases in a dominant manner. The invention also concerns pharmaceutical compositions and detection methods using these sequences.

 
Web www.patentalert.com

< TNF receptor death domain ligand proteins and inhibitors of ligand binding

< Compositions and methods using sub-PPM combinations of polyquaternium-1 and high molecular weight PHMB

> Process for the preparation of lipoic acid and dihydrolipoic acid

> Pharmaceutical composition comprising factor VIII and neutral liposomes
~ 00203